MADISON, Wis., April 4, 2019 /PRNewswire/ — DotCom Therapy, Inc., an industry leader in teletherapy for speech, occupational, and behavioral health services, today announced the appointment Dr. Sanaz Cordes as its new chief executive officer.
Dr. Cordes brings more than 16 years of health and health tech experience to DotCom Therapy, along with a proven track record of growing sales and revenue.
“I’m honored and excited to join this female-founded digital health company,” said Cordes, a known advocate for female entrepreneurs in the venture-backed health tech space. “My focus as CEO is to grow the company and expand our teletherapy services to schools, provider groups, and health systems.”
Prior to joining DotCom Therapy, Dr. Cordes was the founder and principal at Value Prop Shop, a consulting firm focused exclusively on working with health tech startups to strategically scale and grow revenue. She also served as the chief operations officer at healthfinch, a Madison-based tech startup, overseeing sales, marketing and internal operations. Previous roles also include chief development officer at Cogent Health in Nashville and director of strategic partnerships at Zynx Health in Los Angeles. Dr. Cordes began her career as a pediatrician and medical director for Providence Health and Services and holds an MD from UT Southwestern Medical School.
Rachel Robinson, founder and president of DotCom Therapy added, “Sanaz’s varied expertise is unparalleled. Her proven dedication to improving quality and access to healthcare aligns perfectly with our company mission, and we are so grateful to have her a part of our team.”
Since its inception in 2015, DotCom Therapy has experienced rapid market expansion with more than 115 company-employed therapists providing teletherapy to students and patients across 25 states and six countries. The funding from HealthX Ventures will support further development of DotCom Therapy’s technology, the addition of new teletherapy services and continued market expansion.
“DotCom Therapy increases access to high quality therapy for people, regardless of location, while reducing the cost of care,” says Mark Bakken, managing partner at HealthX Ventures. “Sanaz’s leadership in scaling healthcare technology companies and her knowledge as a physician make her uniquely qualified to lead DotCom Therapy into the future.”
DotCom Therapy is the recipient of several awards including Entrepreneur 360 Best Companies and the Wisconsin Innovation Award. Through collaboration with leaders in the education and healthcare space, DotCom Therapy continues to create solutions that improve the quality and experience of teletherapy services.
About DotCom Therapy
Founded in 2015, DotCom Therapy is the leading teletherapy provider offering unparalleled speech, occupational, and behavioral therapy services via a face-to-face, online platform. DotCom Therapy’s outstanding team of therapists, combined with an intuitive platform, provide an exceptional user experience for their clients. The company is committed to making high quality therapy available to everyone, everywhere. Learn more at www.dotcomtherapy.com.
About HealthX Ventures
HealthX Ventures is a digital healthcare-focused venture capital fund based in Madison, Wisconsin. HealthX supports early stage, high-growth companies who are making healthcare safer, more efficient, and more affordable by delivering easy-to-use, cost-effective, and scalable solutions to the market.
View original content to download multimedia:http://www.prnewswire.com/news-releases/dr-sanaz-cordes-named-chief-executive-officer-of-dotcom-therapy-300824436.html
SOURCE DotCom Therapy
HeartBeam system was recently cleared by US Food and Drug Administration (FDA) for comprehensive arrhythmia…
ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused…
This generous grant will directly benefit the NCCS's Beyond the Cure Ambassador Scholarship Program, which…
Medical Co-working space challenges broken healthcare system. HOUSTON, TEXAS / ACCESSWIRE / December 23, 2024…
SAN DIEGO, CALIFORNIA / ACCESSWIRE / December 23, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce"…
MIAMI, FL / ACCESSWIRE / December 23, 2024 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), or the…